These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 29905864)

  • 1. Pathogenic variant in EPHB4 results in central conducting lymphatic anomaly.
    Li D; Wenger TL; Seiler C; March ME; Gutierrez-Uzquiza A; Kao C; Bhoj E; Tian L; Rosenbach M; Liu Y; Robinson N; Behr M; Chiavacci R; Hou C; Wang T; Bakay M; Pellegrino da Silva R; Perkins JA; Sleiman P; Levine MA; Hicks PJ; Itkin M; Dori Y; Hakonarson H
    Hum Mol Genet; 2018 Sep; 27(18):3233-3245. PubMed ID: 29905864
    [TBL] [Abstract][Full Text] [Related]  

  • 2. RASA1 functions in EPHB4 signaling pathway to suppress endothelial mTORC1 activity.
    Kawasaki J; Aegerter S; Fevurly RD; Mammoto A; Mammoto T; Sahin M; Mably JD; Fishman SJ; Chan J
    J Clin Invest; 2014 Jun; 124(6):2774-84. PubMed ID: 24837431
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Loss of function mutations in EPHB4 are responsible for vein of Galen aneurysmal malformation.
    Vivanti A; Ozanne A; Grondin C; Saliou G; Quevarec L; Maurey H; Aubourg P; Benachi A; Gut M; Gut I; Martinovic J; Sénat MV; Tawk M; Melki J
    Brain; 2018 Apr; 141(4):979-988. PubMed ID: 29444212
    [TBL] [Abstract][Full Text] [Related]  

  • 4. EPHB4 kinase-inactivating mutations cause autosomal dominant lymphatic-related hydrops fetalis.
    Martin-Almedina S; Martinez-Corral I; Holdhus R; Vicente A; Fotiou E; Lin S; Petersen K; Simpson MA; Hoischen A; Gilissen C; Jeffery H; Atton G; Karapouliou C; Brice G; Gordon K; Wiseman JW; Wedin M; Rockson SG; Jeffery S; Mortimer PS; Snyder MP; Berland S; Mansour S; Makinen T; Ostergaard P
    J Clin Invest; 2016 Aug; 126(8):3080-8. PubMed ID: 27400125
    [TBL] [Abstract][Full Text] [Related]  

  • 5. EphrinB2-EphB4 signalling provides Rho-mediated homeostatic control of lymphatic endothelial cell junction integrity.
    Frye M; Stritt S; Ortsäter H; Hernandez Vasquez M; Kaakinen M; Vicente A; Wiseman J; Eklund L; Martínez-Torrecuadrada JL; Vestweber D; Mäkinen T
    Elife; 2020 Sep; 9():. PubMed ID: 32897857
    [TBL] [Abstract][Full Text] [Related]  

  • 6. EphrinB2-EphB4 signals regulate formation and maintenance of funnel-shaped valves in corneal lymphatic capillaries.
    Katsuta H; Fukushima Y; Maruyama K; Hirashima M; Nishida K; Nishikawa S; Uemura A
    Invest Ophthalmol Vis Sci; 2013 Jun; 54(6):4102-8. PubMed ID: 23696610
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Germline Loss-of-Function Mutations in EPHB4 Cause a Second Form of Capillary Malformation-Arteriovenous Malformation (CM-AVM2) Deregulating RAS-MAPK Signaling.
    Amyere M; Revencu N; Helaers R; Pairet E; Baselga E; Cordisco M; Chung W; Dubois J; Lacour JP; Martorell L; Mazereeuw-Hautier J; Pyeritz RE; Amor DJ; Bisdorff A; Blei F; Bombei H; Dompmartin A; Brooks D; Dupont J; González-Enseñat MA; Frieden I; Gérard M; Kvarnung M; Hanson-Kahn AK; Hudgins L; Léauté-Labrèze C; McCuaig C; Metry D; Parent P; Paul C; Petit F; Phan A; Quere I; Salhi A; Turner A; Vabres P; Vicente A; Wargon O; Watanabe S; Weibel L; Wilson A; Willing M; Mulliken JB; Boon LM; Vikkula M
    Circulation; 2017 Sep; 136(11):1037-1048. PubMed ID: 28687708
    [TBL] [Abstract][Full Text] [Related]  

  • 8. ARAF recurrent mutation causes central conducting lymphatic anomaly treatable with a MEK inhibitor.
    Li D; March ME; Gutierrez-Uzquiza A; Kao C; Seiler C; Pinto E; Matsuoka LS; Battig MR; Bhoj EJ; Wenger TL; Tian L; Robinson N; Wang T; Liu Y; Weinstein BM; Swift M; Jung HM; Kaminski CN; Chiavacci R; Perkins JA; Levine MA; Sleiman PMA; Hicks PJ; Strausbaugh JT; Belasco JB; Dori Y; Hakonarson H
    Nat Med; 2019 Jul; 25(7):1116-1122. PubMed ID: 31263281
    [TBL] [Abstract][Full Text] [Related]  

  • 9. SAM domain variants of EPHB4 associated with aberrant signaling are linked to lymphatic-related fetal hydrops and facial dysmorphology.
    Vanden Broek K; Ryu JR; Perrier R; Tyndall AV; Childs SJ; Au PYB
    Clin Genet; 2024 Apr; 105(4):386-396. PubMed ID: 38151336
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PDZ interaction site in ephrinB2 is required for the remodeling of lymphatic vasculature.
    Mäkinen T; Adams RH; Bailey J; Lu Q; Ziemiecki A; Alitalo K; Klein R; Wilkinson GA
    Genes Dev; 2005 Feb; 19(3):397-410. PubMed ID: 15687262
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lymphatic Malformations: Genetics, Mechanisms and Therapeutic Strategies.
    Mäkinen T; Boon LM; Vikkula M; Alitalo K
    Circ Res; 2021 Jun; 129(1):136-154. PubMed ID: 34166072
    [TBL] [Abstract][Full Text] [Related]  

  • 12. EphB4 forward signalling regulates lymphatic valve development.
    Zhang G; Brady J; Liang WC; Wu Y; Henkemeyer M; Yan M
    Nat Commun; 2015 Apr; 6():6625. PubMed ID: 25865237
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Janus-faced EPHB4-associated disorders: novel pathogenic variants and unreported intrafamilial overlapping phenotypes.
    Martin-Almedina S; Ogmen K; Sackey E; Grigoriadis D; Karapouliou C; Nadarajah N; Ebbing C; Lord J; Mellis R; Kortuem F; Dinulos MB; Polun C; Bale S; Atton G; Robinson A; Reigstad H; Houge G; von der Wense A; Becker WH; Jeffery S; Mortimer PS; Gordon K; Josephs KS; Robart S; Kilby MD; Vallee S; Gorski JL; Hempel M; Berland S; Mansour S; Ostergaard P
    Genet Med; 2021 Jul; 23(7):1315-1324. PubMed ID: 33864021
    [TBL] [Abstract][Full Text] [Related]  

  • 14. EPHB4-RASA1 Inhibition of PIEZO1 Ras Activation Drives Lymphatic Valvulogenesis.
    Chen D; Tang Y; Lapinski PE; Wiggins D; Sevick EM; Davis MJ; King PD
    Circ Res; 2024 Nov; 135(11):1048-1066. PubMed ID: 39421925
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The YAP signaling pathway promotes the progression of lymphatic malformations through the activation of lymphatic endothelial cells.
    Zhong W; Jiang H; Zou Y; Ren J; Li Z; He K; Zhao J; Zhou X; Mou D; Cai Y
    Pediatr Res; 2021 Jan; 89(1):110-117. PubMed ID: 32279070
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Angiogenesis depends upon EPHB4-mediated export of collagen IV from vascular endothelial cells.
    Chen D; Hughes ED; Saunders TL; Wu J; Vasquez MNH; Makinen T; King PD
    JCI Insight; 2022 Feb; 7(4):. PubMed ID: 35015735
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Kinome multigenic panel identified novel druggable EPHB4-V871I somatic variant in high-risk neuroblastoma.
    Andolfo I; Lasorsa VA; Manna F; Rosato BE; Formicola D; Iolascon A; Capasso M
    J Cell Mol Med; 2020 Jun; 24(11):6459-6471. PubMed ID: 32336043
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Functions and Regeneration of Mature Cardiac Lymphatic Vessels in Atherosclerosis, Myocardial Infarction, and Heart Failure.
    Zhang Y; Bai Y; Jing Q; Qian J
    Lymphat Res Biol; 2018 Dec; 16(6):507-515. PubMed ID: 30339474
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phenotype of CM-AVM2 caused by variants in EPHB4: how much overlap with hereditary hemorrhagic telangiectasia (HHT)?
    Wooderchak-Donahue WL; Akay G; Whitehead K; Briggs E; Stevenson DA; O'Fallon B; Velinder M; Farrell A; Shen W; Bedoukian E; Skrabann CM; Antaya RJ; Henderson K; Pollak J; Treat J; Day R; Jacher JE; Hannibal M; Bontempo K; Marth G; Bayrak-Toydemir P; McDonald J
    Genet Med; 2019 Sep; 21(9):2007-2014. PubMed ID: 30760892
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pathogenic variants in
    Byrne AB; Brouillard P; Sutton DL; Kazenwadel J; Montazaribarforoushi S; Secker GA; Oszmiana A; Babic M; Betterman KL; Brautigan PJ; White M; Piltz SG; Thomas PQ; Hahn CN; Rath M; Felbor U; Korenke GC; Smith CL; Wood KH; Sheppard SE; Adams DM; Kariminejad A; Helaers R; Boon LM; Revencu N; Moore L; Barnett C; Haan E; Arts P; Vikkula M; Scott HS; Harvey NL
    Sci Transl Med; 2022 Mar; 14(634):eabm4869. PubMed ID: 35235341
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.